vlp nanoparticles Search Results


f-protein virus-like nanoparticle (vlp) vaccine  (Novavax Inc)
90
Novavax Inc f-protein virus-like nanoparticle (vlp) vaccine
F Protein Virus Like Nanoparticle (Vlp) Vaccine, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/f-protein virus-like nanoparticle (vlp) vaccine/product/Novavax Inc
Average 90 stars, based on 1 article reviews
f-protein virus-like nanoparticle (vlp) vaccine - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
recombinant s proteins on their proprietary vlp nanoparticles  (Novavax Inc)
90
Novavax Inc recombinant s proteins on their proprietary vlp nanoparticles
Recombinant S Proteins On Their Proprietary Vlp Nanoparticles, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant s proteins on their proprietary vlp nanoparticles/product/Novavax Inc
Average 90 stars, based on 1 article reviews
recombinant s proteins on their proprietary vlp nanoparticles - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
vlv-based nanoparticle cdc vlp expressed dna plasmid  (CaroGen Corporation)
90
CaroGen Corporation vlv-based nanoparticle cdc vlp expressed dna plasmid
Examples of Zika Virus Vaccines Under Investigation in the United States 146 , 167 – 174
Vlv Based Nanoparticle Cdc Vlp Expressed Dna Plasmid, supplied by CaroGen Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vlv-based nanoparticle cdc vlp expressed dna plasmid/product/CaroGen Corporation
Average 90 stars, based on 1 article reviews
vlv-based nanoparticle cdc vlp expressed dna plasmid - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
assembled vlp nanoparticle  (Cold Spring Harbor Laboratory Meetings)
90
Cold Spring Harbor Laboratory Meetings assembled vlp nanoparticle
Examples of Zika Virus Vaccines Under Investigation in the United States 146 , 167 – 174
Assembled Vlp Nanoparticle, supplied by Cold Spring Harbor Laboratory Meetings, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/assembled vlp nanoparticle/product/Cold Spring Harbor Laboratory Meetings
Average 90 stars, based on 1 article reviews
assembled vlp nanoparticle - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
f-protein vlp nanoparticle vaccine  (Novavax Inc)
90
Novavax Inc f-protein vlp nanoparticle vaccine
Vaccine types. A, Live attenuated vaccines are grown in culture to make them less virulent but can have the problem of reversion. B, Inactivated vaccines are treated with UV or formaldehyde to crosslink proteins and make them nonviable. C, Proteins can be purified, extracted, or dissolved by using detergents. D, Naked nucleic acids are also used as vaccines. E, <t>Nanoparticle</t> vaccines encompass natural and synthetic materials. Membranes can be used to make liposomes to contain and deliver an antigen to a target cell. F, Viruses can have nucleic acid and core protein removed to form virosomes. G, Viral proteins, such as HA stalks or antigens, can be engineered onto immunogenic core proteins (eg, ferritin or vaults). This example is HA on ferritin adapted from PBD codes 3BVE and 5C0S. H, Viruses, such as the vaccinia virus Ankara, with coat proteins and genetic material removed can be engineered to express other antigens, such as influenza M2 ion channel protein. I, VLPs can be engineered to express antigens and naturally glycosylated proteins and have adjuvants incorporated into the coat. PAMP , Pathogen-associated molecular pattern. J, Synthetic nanoparticles made from polymers (polystyrene or poly lactic-co-glycolic acid), gold, or carbon nanotubes can have peptides adsorbed, admixed, or encapsulated. Ag , Antigen.
F Protein Vlp Nanoparticle Vaccine, supplied by Novavax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/f-protein vlp nanoparticle vaccine/product/Novavax Inc
Average 90 stars, based on 1 article reviews
f-protein vlp nanoparticle vaccine - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
non-vlp nanoparticle ebs-ufv-001  (Emergent BioSolutions Inc)
90
Emergent BioSolutions Inc non-vlp nanoparticle ebs-ufv-001
Vaccine types. A, Live attenuated vaccines are grown in culture to make them less virulent but can have the problem of reversion. B, Inactivated vaccines are treated with UV or formaldehyde to crosslink proteins and make them nonviable. C, Proteins can be purified, extracted, or dissolved by using detergents. D, Naked nucleic acids are also used as vaccines. E, <t>Nanoparticle</t> vaccines encompass natural and synthetic materials. Membranes can be used to make liposomes to contain and deliver an antigen to a target cell. F, Viruses can have nucleic acid and core protein removed to form virosomes. G, Viral proteins, such as HA stalks or antigens, can be engineered onto immunogenic core proteins (eg, ferritin or vaults). This example is HA on ferritin adapted from PBD codes 3BVE and 5C0S. H, Viruses, such as the vaccinia virus Ankara, with coat proteins and genetic material removed can be engineered to express other antigens, such as influenza M2 ion channel protein. I, VLPs can be engineered to express antigens and naturally glycosylated proteins and have adjuvants incorporated into the coat. PAMP , Pathogen-associated molecular pattern. J, Synthetic nanoparticles made from polymers (polystyrene or poly lactic-co-glycolic acid), gold, or carbon nanotubes can have peptides adsorbed, admixed, or encapsulated. Ag , Antigen.
Non Vlp Nanoparticle Ebs Ufv 001, supplied by Emergent BioSolutions Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-vlp nanoparticle ebs-ufv-001/product/Emergent BioSolutions Inc
Average 90 stars, based on 1 article reviews
non-vlp nanoparticle ebs-ufv-001 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Examples of Zika Virus Vaccines Under Investigation in the United States 146 , 167 – 174

Journal: Pharmacy and Therapeutics

Article Title: Zika in America: The Year in Review

doi:

Figure Lengend Snippet: Examples of Zika Virus Vaccines Under Investigation in the United States 146 , 167 – 174

Article Snippet: Some key hurdles include: 1 , 175 , 176 table ft1 table-wrap mode="anchored" t5 caption a7 Developer Technology CaroGen Corp. VLV-based nanoparticle CDC VLP expressed by DNA plasmid; live recombinant adenovirus GeoVax Labs, Inc. MVA-VLP technology elicits antibodies and T cells Hawaii Biotech Recombinant proteins produced from insect cell line, plus Alhydrogel or proprietary adjuvant Inovio/GeneOne Life Science DNA (electroporation) Kansas State University DNA NewLink Genetics Corp. Purified inactivated virus NIH Zika-targeted mutation, live attenuated (longer-term); DNA; live VSV recombinant Novavax E protein (nanoparticles) Pharos Biologicals, Inc. Nanosphere delivery Protein Sciences Corp. Recombinant variations of Zika virus E protein Replikins, Ltd.

Techniques: Plasmid Preparation, Recombinant, Produced, Electroporation, Purification, Mutagenesis

Vaccine types. A, Live attenuated vaccines are grown in culture to make them less virulent but can have the problem of reversion. B, Inactivated vaccines are treated with UV or formaldehyde to crosslink proteins and make them nonviable. C, Proteins can be purified, extracted, or dissolved by using detergents. D, Naked nucleic acids are also used as vaccines. E, Nanoparticle vaccines encompass natural and synthetic materials. Membranes can be used to make liposomes to contain and deliver an antigen to a target cell. F, Viruses can have nucleic acid and core protein removed to form virosomes. G, Viral proteins, such as HA stalks or antigens, can be engineered onto immunogenic core proteins (eg, ferritin or vaults). This example is HA on ferritin adapted from PBD codes 3BVE and 5C0S. H, Viruses, such as the vaccinia virus Ankara, with coat proteins and genetic material removed can be engineered to express other antigens, such as influenza M2 ion channel protein. I, VLPs can be engineered to express antigens and naturally glycosylated proteins and have adjuvants incorporated into the coat. PAMP , Pathogen-associated molecular pattern. J, Synthetic nanoparticles made from polymers (polystyrene or poly lactic-co-glycolic acid), gold, or carbon nanotubes can have peptides adsorbed, admixed, or encapsulated. Ag , Antigen.

Journal: The Journal of Allergy and Clinical Immunology

Article Title: Promising approaches for the treatment and prevention of viral respiratory illnesses

doi: 10.1016/j.jaci.2017.07.001

Figure Lengend Snippet: Vaccine types. A, Live attenuated vaccines are grown in culture to make them less virulent but can have the problem of reversion. B, Inactivated vaccines are treated with UV or formaldehyde to crosslink proteins and make them nonviable. C, Proteins can be purified, extracted, or dissolved by using detergents. D, Naked nucleic acids are also used as vaccines. E, Nanoparticle vaccines encompass natural and synthetic materials. Membranes can be used to make liposomes to contain and deliver an antigen to a target cell. F, Viruses can have nucleic acid and core protein removed to form virosomes. G, Viral proteins, such as HA stalks or antigens, can be engineered onto immunogenic core proteins (eg, ferritin or vaults). This example is HA on ferritin adapted from PBD codes 3BVE and 5C0S. H, Viruses, such as the vaccinia virus Ankara, with coat proteins and genetic material removed can be engineered to express other antigens, such as influenza M2 ion channel protein. I, VLPs can be engineered to express antigens and naturally glycosylated proteins and have adjuvants incorporated into the coat. PAMP , Pathogen-associated molecular pattern. J, Synthetic nanoparticles made from polymers (polystyrene or poly lactic-co-glycolic acid), gold, or carbon nanotubes can have peptides adsorbed, admixed, or encapsulated. Ag , Antigen.

Article Snippet: Recent preclinical results exhibit effective neutralization of RSV., , , , The most advanced of these is the Novavax F-protein VLP nanoparticle vaccine with aluminum hydroxide adjuvant, which is in phase III for maternal vaccination., Transplacental transmission of neutralizing antibodies has been demonstrated in preclinical studies, although this has not conferred significant protection from RSV.

Techniques: Vaccines, Purification, Liposomes, Virus

IFV and RSV vaccines and mAbs currently in clinical trials

Journal: The Journal of Allergy and Clinical Immunology

Article Title: Promising approaches for the treatment and prevention of viral respiratory illnesses

doi: 10.1016/j.jaci.2017.07.001

Figure Lengend Snippet: IFV and RSV vaccines and mAbs currently in clinical trials

Article Snippet: Recent preclinical results exhibit effective neutralization of RSV., , , , The most advanced of these is the Novavax F-protein VLP nanoparticle vaccine with aluminum hydroxide adjuvant, which is in phase III for maternal vaccination., Transplacental transmission of neutralizing antibodies has been demonstrated in preclinical studies, although this has not conferred significant protection from RSV.

Techniques: Vaccines, Adjuvant, Plasmid Preparation, Recombinant, Formulation, Expressing, Clinical Proteomics